Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Skin Patch Monitors Tumor Size and Sends Data to Smartphone

By HospiMedica International staff writers
Posted on 26 Jan 2024

Certain tumors form just beneath the skin's surface, and doctors often opt not to remove them immediately for various medical reasons. More...

These tumors are generally managed with medications and radiation therapy. In these situations, it's crucial for healthcare professionals to regularly assess the tumor's size to evaluate the effectiveness of the treatments. This typically requires patients to visit a medical facility for tests like MRIs to measure the tumor. Now, researchers have created a skin patch capable of monitoring the size of tumors lying just under the skin, a development that has been successfully tested on mice.

Researchers from National Tsing Hua University (Hsinchu, Taiwan) and Taipei Medical University (Taipei, Taiwan) discovered a simpler method for measuring tumors just under the skin. They developed a skin patch that continuously monitors tumor size through a smartphone application. The patch, resembling a flexible sticker, is made from soft, elastic plastic with an adhesive on one side. To transform this into a monitoring device, the team incorporated hafnium, a metal formed by combining silver and oxygen, into the plastic. This metal was processed into nanoparticles of 100 nm in size and then mixed with the plastic.

Once the patch is applied over a tumor, the patch properties are altered by changes in the alignment of the nanoparticles and their electrical properties to reveal the size of the tumor. The researchers validated this technology on mice with tumors approximately the size of a grain of rice and found it could accurately monitor the tumor size for up to a week. The research team envisages that, upon further validation and clinical use, this patch would allow patients to personally monitor their treatment progress. Additionally, the data collected by the smartphone app could be sent daily to their healthcare provider, potentially enhancing patient care and treatment monitoring.

Related Links:
National Tsing Hua University
Taipei Medical University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.